Literature DB >> 25900215

Description of Kampo medicines in the clinical practice guidelines for irritable bowel syndrome.

Yoshiharu Motoo1.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 25900215     DOI： 10.1007/s00535-015-1075-y

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN： 0944-1174            Impact factor:   7.527


× No keyword cloud information.
  1 in total

1.  Evidence-based clinical practice guidelines for irritable bowel syndrome.

Authors:  Shin Fukudo; Hiroshi Kaneko; Hirotada Akiho; Masahiko Inamori; Yuka Endo; Toshikatsu Okumura; Motoyori Kanazawa; Takeshi Kamiya; Ken Sato; Toshimi Chiba; Kenji Furuta; Shigeru Yamato; Tetsuo Arakawa; Yoshihide Fujiyama; Takeshi Azuma; Kazuma Fujimoto; Tetsuya Mine; Soichiro Miura; Yoshikazu Kinoshita; Kentaro Sugano; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2014-12-12       Impact factor: 7.527
  1 in total
  1 in total

1.  Evaluation of Kampo medicine in the clinical practice guideline for irritable bowel syndrome.

Authors:  Shin Fukudo; Hiroshi Kaneko; Hirotada Akiho; Masahiko Inamori; Yuka Endo; Toshikatsu Okumura; Motoyori Kanazawa; Takeshi Kamiya; Ken Sato; Toshimi Chiba; Kenji Furuta; Shigeru Yamato; Tetsuo Arakawa; Yoshihide Fujiyama; Takeshi Azuma; Kazuma Fujimoto; Tetsuya Mine; Soichiro Miura; Yoshikazu Kinoshita; Mamoru Watanabe; Kentaro Sugano; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2015-06-23       Impact factor: 7.527
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.